Health Care: Drugs

Merrimack Pharmaceuticals Inc (MACK: NASDAQ)

$7.29 n/a | n/a%
09/19/14 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 7.29
52 Week High 8.25
52 Week Low 2.05
Avg. Daily Vol. (Mil) 1.37
Beta (3 year) 1.57
Share Related Items
Mkt Cap (Mil) 762.44
Shares Out (Mil) 104.59
Float (Mil) 80.74
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 1.10
Current Ratio 1.10
LT Debt/ Equity 0.00
Total Debt / Equity n.a.
Valuation Ratios
Price Earnings n.a.
Price/Sales 13.73
Price/Book 0.00
Price/Cash Flow -6.70
Per Share Data
Earnings -1.16
Sales 0.53
Book Value 0.00
Cash Flow -1.10
Business Summary
Merrimack Pharmaceuticals Inc is engaged in discovering, developing and preparing to commercialize medicines consisting of novel therapeutics paired with companion diagnostics for the treatment of cancer.
General Information
One Kendall Square
Suite B7201
Cambridge, MA 02139
www.merrimackpharma.com
Industry : Drugs
Sector: Health Care
Employees: 254
CEO: Robert J. Mulroy
Short Interest
Current Month (Mil) 17.12
Previous Month (Mil) 17.25
Short Interest Ratio (Days) 12.20
Management Effectiveness
Return on Equity n.a.
Return on Assets -91.00
Return on Investments -421.60
Profitability
Gross Margin -70.20
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with MACK

Latest MACK Headlines from TheStreet

More Financial News for MACK

Press Releases for MACK

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter